Paul Tudor Jones Inogen Inc Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Inogen Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 57,171 shares of INGN stock, worth $511,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,171

Previous 32,147 77.84%

Holding current value

$511,680

Previous $261,000 112.26%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.67 - $12.98 $191,934 - $324,811	25,024 Added 77.84%	57,171 $554,000
Q2 2024 Aug 14, 2024	SELL	$6.3 - $8.95 $311,409 - $442,398	-49,430 Reduced 60.59%	32,147 $261,000
Q1 2024 May 15, 2024	BUY	$5.26 - $10.15 $123,999 - $239,276	23,574 Added 40.64%	81,577 $658,000
Q4 2023 Feb 14, 2024	BUY	$4.21 - $6.32 $84,056 - $126,185	19,966 Added 52.49%	58,003 $318,000
Q3 2023 Nov 15, 2023	BUY	$5.14 - $11.28 $195,510 - $429,057	38,037 New	38,037 $198,000
Q1 2020 May 15, 2020	SELL	$32.63 - $67.59 $317,555 - $657,785	-9,732 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$45.95 - $76.15 $1.88 Million - $3.11 Million	-40,826 Reduced 80.75%	9,732 $665,000
Q3 2019 Nov 14, 2019	BUY	$41.82 - $66.71 $958,054 - $1.53 Million	22,909 Added 82.86%	50,558 $2.42 Million
Q2 2019 Aug 14, 2019	BUY	$63.19 - $95.15 $519,105 - $781,657	8,215 Added 42.27%	27,649 $1.85 Million
Q1 2019 May 15, 2019	BUY	$90.12 - $152.23 $1.75 Million - $2.96 Million	19,434 New	19,434 $1.85 Million
Q4 2018 Feb 14, 2019	SELL	$112.83 - $239.74 $1.74 Million - $3.69 Million	-15,406 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $2.91 Million - $4.36 Million	15,406 New	15,406 $3.76 Million

Others Institutions Holding INGN

# of Institutions

143

Shares Held

21M

Call Options Held

119K

Put Options Held

149K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $205M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account